Evaluation of a bracketing calibration-based isotope dilution liquid chromatography–tandem mass spectrometry candidate reference measurement procedure for 17α-hydroxyprogesterone in human plasma

被引:0
作者
Qiaoxuan Zhang
Lu Zhang
Haibiao Lin
Zhiliang Cai
Jun Yan
Qiqin Wang
Liqiao Han
Jianbing Wang
Peifeng Ke
Junhua Zhuang
Xianzhang Huang
机构
[1] The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Department of Laboratory Medicine
[2] Guangzhou University of Chinese Medicine,Second Clinical Medical College
[3] Jinan University,Department of Pharmacy and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine & New Drug Research
来源
Analytical and Bioanalytical Chemistry | 2019年 / 411卷
关键词
17α-Hydroxyprogesterone; Reference measurement procedure; Tandem mass spectrometry; Clinical laboratory measurements;
D O I
暂无
中图分类号
学科分类号
摘要
A candidate reference measurement procedure (RMP) based on isotope dilution coupled with liquid chromatography–tandem mass spectrometry (ID–LC–MS/MS) was developed and validated for the quantification of 17α-hydroxyprogesterone (17-OHP) in human plasma. 17-OHP spiked with a deuterium-labeled internal standard was extracted from plasma by liquid–liquid extraction with 1 mL n-hexane/ethyl acetate (3:2, v/v). Reversed-phase chromatography and positive electrospray ionization were used in the ID–LC–MS/MS. Gradient elution coupled with use of a C18-packed ultrahigh-performance liquid chromatography column allowed complete baseline resolution of 17-OHP from its structural analogue desoxycorticosterone in 6 min. To determine the 17-OHP level in human plasma, a bracketing calibration method was used to give higher accuracy and precision. The limit of detection and the lower limit of the measuring interval for the candidate RMP were 2.1 pg/mL (6.4 pmol/L) and 4.6 pg/mL (13.9 pmol/L), respectively. Extraction recovery was determined to be (96.08 ± 3.03)% (n = 3). Imprecision (intra-assay and interassay) was 4.03% or less at 0.83, 15.19, 64.22, and 313.46 ng/mL (2.51, 45.97, 194.34, and 948.56 nmol/L, respectively). Recoveries ranged from 98.05% to 102.24%. When comparing our RMP results with those obtained with an established RMP via International Federation of Clinical Chemistry and Laboratory Medicine external quality assessment scheme for reference laboratories in laboratory medicine (RELA) samples, we found that the biases ranged from -1.99% to 3.08% against the targets. No interference was observed, and the linear response ranged from 0.47 to 958.63 ng/mL (1.42 to 2900.90 nmol/L). Moreover, the candidate RMP was used to measure the concentration of 17-OHP in human plasma and was compared with an immunoassay using 40 plasma samples. The performance of the method meets the needs of an RMP (total coefficient of variation of 5% or less and bias of 3.08% or less). This method can be used for reference material value assignment of 17-OHP in human plasma matrix. It could also serve as an accurate reference baseline for routine methods to increase the accuracy and precision of certain clinical laboratory measurements.
引用
收藏
页码:7095 / 7104
页数:9
相关论文
共 91 条
[1]  
Reinehr T(2018)Vanishing 17-hydroxyprogesterone concentrations in 21-hydroxylase deficiency Horm Res Paediatr 90 138-144
[2]  
Rothermel J(2010)Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening Clin Chim Acta 411 1684-1687
[3]  
Wegener-Panzer A(2018)Basal levels of 17-hydroxyprogesterone can distinguish children with isolated precocious pubarche Pediatr Res 84 533-536
[4]  
Hartmann MF(2019)Newborn screening for congenital adrenal hyperplasia: beyond 17-hydroxyprogesterone concentrations J Pediatr 95 257-259
[5]  
Wudy SA(2014)Polycystic ovary syndrome: update on diagnosis and treatment Am J Med 127 912-919
[6]  
Holterhus PM(2002)Limitations of steroid determination by direct immunoassay Clin Chem 48 583-585
[7]  
De Jesus VR(2004)Improving neonatal screening for congenital adrenal hyperplasia J Clin Endocrinol Metab 89 3685-3686
[8]  
Simms DA(2009)False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17α-hydroxyprogesterone (17-OHP) values Steroids. 74 662-665
[9]  
Schiffer J(2005)Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency Clin Chem 51 298-304
[10]  
Kennedy M(2016)Evaluation of an isotope dilution HPLC tandem mass spectrometry candidate reference measurement procedure for total 17-β estradiol in human serum Anal Chem 88 11123-11129